Roberta Alfieri
Roberta Alfieri
Associate Professor in General Pathology, University of Parma
Email verificata su
Citata da
Citata da
Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer
C Fumarola, MA Bonelli, PG Petronini, RR Alfieri
Biochemical pharmacology 90 (3), 197-207, 2014
Damage to nuclear DNA induced by Shiga toxin 1 and ricin in human endothelial cells1
M Brigotti, R Alfieri, P Sestili, M Bonelli, PG Petronini, A Guidarelli, ...
The FASEB Journal 16 (3), 365-372, 2002
Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer
Y Li, SM Meeran, SN Patel, H Chen, TM Hardy, TO Tollefsbol
Molecular cancer 12 (1), 1-17, 2013
Compatible osmolytes modulate the response of porcine endothelial cells to hypertonicity and protect them from apoptosis
RR Alfieri, A Cavazzoni, PG Petronini, MA Bonelli, AE Caccamo, ...
The Journal of Physiology 540 (2), 499-508, 2002
Hyperosmotic stress response: comparison with other cellular stresses
RR Alfieri, PG Petronini
Pflgers Archiv-European Journal of Physiology 454 (2), 173-185, 2007
5-Benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity
C Carmi, A Cavazzoni, V Zuliani, A Lodola, F Bordi, PV Plazzi, RR Alfieri, ...
Bioorganic & medicinal chemistry letters 16 (15), 4021-4025, 2006
Clinical perspectives for irreversible tyrosine kinase inhibitors in cancer
C Carmi, M Mor, PG Petronini, RR Alfieri
Biochemical pharmacology 84 (11), 1388-1399, 2012
Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines
S La Monica, M Galetti, RR Alfieri, A Cavazzoni, A Ardizzoni, M Tiseo, ...
Biochemical pharmacology 78 (5), 460-468, 2009
Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones
A Cavazzoni, MA Bonelli, C Fumarola, S La Monica, K Airoud, R Bertoni, ...
Cancer letters 323 (1), 77-87, 2012
Cell size reduction induced by inhibition of the mTOR/S6K-signaling pathway protects Jurkat cells from apoptosis
C Fumarola, S La Monica, RR Alfieri, E Borra, GG Guidotti
Cell Death & Differentiation 12 (10), 1344-1357, 2005
Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding site
K Eisermann, CJ Broderick, A Bazarov, MM Moazam, GC Fraizer
Molecular cancer 12 (1), 1-12, 2013
Low PD-1 expression in cytotoxic CD8+ tumor-infiltrating lymphocytes confers an immune-privileged tissue microenvironment in NSCLC with a prognostic and predictive value
G Mazzaschi, D Madeddu, A Falco, G Bocchialini, M Goldoni, F Sogni, ...
Clinical cancer research 24 (2), 407-419, 2018
Synthesis and biological evaluation of tetracyclic fluoroquinolones as antibacterial and anticancer agents
SA Al-Trawneh, JA Zahra, MR Kamal, MM El-Abadelah, F Zani, M Incerti, ...
Bioorganic & medicinal chemistry 18 (16), 5873-5884, 2010
Creatine as a compatible osmolyte in muscle cells exposed to hypertonic stress
RR Alfieri, MA Bonelli, A Cavazzoni, M Brigotti, C Fumarola, P Sestili, ...
The Journal of physiology 576 (2), 391-401, 2006
Effects of osmolarity, ions and compatible osmolytes on cell-free protein synthesis
M Brigotti, PG Petronini, D Carnicelli, RR Alfieri, MA Bonelli, AF Borghetti, ...
Biochemical Journal 369 (2), 369-374, 2003
Novel irreversible epidermal growth factor receptor inhibitors by chemical modulation of the cysteine-trap portion
C Carmi, A Cavazzoni, S Vezzosi, F Bordi, F Vacondio, C Silva, S Rivara, ...
Journal of medicinal chemistry 53 (5), 2038-2050, 2010
Cell susceptibility to apoptosis by glutamine deprivation and rescue: Survival and apoptotic death in cultured lymphoma‐leukemia cell lines
PG Petronini, S Urbani, R Alfieri, AF Borghetti, GG Guidotti
Journal of cellular physiology 169 (1), 175-185, 1996
Dual mechanisms of action of the 5-benzylidene-hydantoin UPR1024 on lung cancer cell lines
A Cavazzoni, RR Alfieri, C Carmi, V Zuliani, M Galetti, C Fumarola, ...
Molecular Cancer Therapeutics 7 (2), 361-370, 2008
Irreversible inhibition of epidermal growth factor receptor activity by 3-aminopropanamides
C Carmi, E Galvani, F Vacondio, S Rivara, A Lodola, S Russo, S Aiello, ...
Journal of medicinal chemistry 55 (5), 2251-2264, 2012
Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK–mTORC1 signaling
C Fumarola, C Caffarra, S La Monica, M Galetti, RR Alfieri, A Cavazzoni, ...
Breast cancer research and treatment 141 (1), 67-78, 2013
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20